Imunon, Inc.
IMNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000749647
In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Imunon, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 24 | 25 | +1 |
| Shares | 525.8K | 919.6K | +393.7K (+74.9%) |
| Value | $2.66M | $1.69M | −$972.2K (−36.6%) |
New holders (5)
Institutions that held Imunon, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Murchinson Ltd. | 276,644 | $509.0K | 0.10% |
| Susquehanna International Group, LLP | 52,274 | $95.0K | 0.00% |
| Citigroup Inc | 11,194 | $20.0K | 0.00% |
| Investors Asset Management of Georgia Inc | 5,000 | $9.00K | 0.00% |
| FMR LLC | 133 | $0 | 0.00% |
Sold out (4)
Institutions that held Imunon, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Citadel Advisors LLC | 32,900 | $166.0K |
| The PNC Financial Services Group, Inc. | 3,333 | $17.0K |
| Benjamin F. Edwards & Company, Inc. | 13 | $0 |
| McCarthy Asset Management, Inc. | 33 | $0 |